Back to trial detailsIntake questionnaire
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Applying to Georgetown University Lombardi Cancer Center · Washington D.C., District of Columbia
Answer a few short questions to share with the research team.
0 of 3 answered